Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reducing Dyskinesia in Parkinson Disease With Omega-3 Fatty Acids

NCT01563913 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT01563913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01563913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reducing Dyskinesia in Parkinson Disease With Omega-3 Fatty Acids
Lead sponsor
VA Office of Research and Development
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2012
Completion date
June 30, 2016
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease